vs

Side-by-side financial comparison of Corteva (CTVA) and Honeywell (HON). Click either name above to swap in a different company.

Honeywell is the larger business by last-quarter revenue ($9.1B vs $4.9B, roughly 1.9× Corteva). Corteva runs the higher net margin — 14.7% vs 8.7%, a 6.0% gap on every dollar of revenue. On growth, Corteva posted the faster year-over-year revenue change (11.0% vs 2.0%). Over the past eight quarters, Honeywell's revenue compounded faster (-2.3% CAGR vs -10.4%).

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

Honeywell International Inc. is an American publicly traded, multinational conglomerate corporation headquartered in Charlotte, North Carolina. It primarily operates in four areas of business: aerospace, building automation, industrial automation, and energy and sustainability solutions (ESS). Honeywell also owns and operates Sandia National Laboratories under contract with the U.S. Department of Energy. Honeywell is a Fortune 500 company, ranked 115th in 2023.

CTVA vs HON — Head-to-Head

Bigger by revenue
HON
HON
1.9× larger
HON
$9.1B
$4.9B
CTVA
Growing faster (revenue YoY)
CTVA
CTVA
+9.0% gap
CTVA
11.0%
2.0%
HON
Higher net margin
CTVA
CTVA
6.0% more per $
CTVA
14.7%
8.7%
HON
Faster 2-yr revenue CAGR
HON
HON
Annualised
HON
-2.3%
-10.4%
CTVA

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CTVA
CTVA
HON
HON
Revenue
$4.9B
$9.1B
Net Profit
$723.0M
$795.0M
Gross Margin
51.6%
Operating Margin
16.1%
Net Margin
14.7%
8.7%
Revenue YoY
11.0%
2.0%
Net Profit YoY
10.4%
-43.3%
EPS (diluted)
$1.07
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTVA
CTVA
HON
HON
Q1 26
$4.9B
$9.1B
Q4 25
$3.9B
$6.9B
Q3 25
$2.6B
$10.4B
Q2 25
$6.5B
$10.4B
Q1 25
$4.4B
$9.8B
Q4 24
$4.0B
$10.1B
Q3 24
$2.3B
$9.7B
Q2 24
$6.1B
$9.6B
Net Profit
CTVA
CTVA
HON
HON
Q1 26
$723.0M
$795.0M
Q4 25
$-552.0M
$-115.0M
Q3 25
$-320.0M
$1.8B
Q2 25
$1.3B
$1.6B
Q1 25
$652.0M
$1.4B
Q4 24
$-41.0M
$1.3B
Q3 24
$-524.0M
$1.4B
Q2 24
$1.1B
$1.5B
Gross Margin
CTVA
CTVA
HON
HON
Q1 26
51.6%
Q4 25
42.4%
36.1%
Q3 25
37.2%
31.1%
Q2 25
54.6%
35.4%
Q1 25
47.0%
35.2%
Q4 24
37.3%
36.4%
Q3 24
32.7%
35.1%
Q2 24
52.3%
35.0%
Operating Margin
CTVA
CTVA
HON
HON
Q1 26
16.1%
Q4 25
-13.6%
16.0%
Q3 25
-14.1%
23.1%
Q2 25
27.9%
22.9%
Q1 25
17.7%
23.0%
Q4 24
2.2%
21.6%
Q3 24
-27.2%
23.6%
Q2 24
21.9%
23.0%
Net Margin
CTVA
CTVA
HON
HON
Q1 26
14.7%
8.7%
Q4 25
-14.1%
-1.7%
Q3 25
-12.2%
17.5%
Q2 25
20.4%
15.2%
Q1 25
14.8%
14.8%
Q4 24
-1.0%
12.7%
Q3 24
-22.5%
14.5%
Q2 24
17.2%
16.1%
EPS (diluted)
CTVA
CTVA
HON
HON
Q1 26
$1.07
$1.29
Q4 25
$-0.80
$-0.17
Q3 25
$-0.47
$2.86
Q2 25
$1.92
$2.45
Q1 25
$0.95
$2.22
Q4 24
$-0.05
$1.96
Q3 24
$-0.76
$2.16
Q2 24
$1.51
$2.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTVA
CTVA
HON
HON
Cash + ST InvestmentsLiquidity on hand
$2.0B
$12.4B
Total DebtLower is stronger
$3.4B
$32.1B
Stockholders' EquityBook value
$24.6B
Total Assets
$42.7B
$74.0B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTVA
CTVA
HON
HON
Q1 26
$2.0B
$12.4B
Q4 25
$4.5B
$12.9B
Q3 25
$2.6B
$13.4B
Q2 25
$2.1B
$10.7B
Q1 25
$2.0B
$10.1B
Q4 24
$3.2B
$11.0B
Q3 24
$2.5B
$10.9B
Q2 24
$2.0B
$9.8B
Total Debt
CTVA
CTVA
HON
HON
Q1 26
$3.4B
$32.1B
Q4 25
$1.7B
$27.1B
Q3 25
$1.7B
$30.1B
Q2 25
$1.7B
$30.2B
Q1 25
$1.8B
$25.7B
Q4 24
$2.0B
$25.5B
Q3 24
$2.0B
$25.9B
Q2 24
$2.5B
$20.9B
Stockholders' Equity
CTVA
CTVA
HON
HON
Q1 26
$24.6B
Q4 25
$24.1B
$13.9B
Q3 25
$25.2B
$16.8B
Q2 25
$25.9B
$16.1B
Q1 25
$24.3B
$17.5B
Q4 24
$23.8B
$18.6B
Q3 24
$24.7B
$17.4B
Q2 24
$25.2B
$16.9B
Total Assets
CTVA
CTVA
HON
HON
Q1 26
$42.7B
$74.0B
Q4 25
$42.8B
$73.7B
Q3 25
$42.2B
$80.9B
Q2 25
$41.8B
$78.4B
Q1 25
$42.1B
$75.2B
Q4 24
$40.8B
$75.2B
Q3 24
$41.9B
$73.5B
Q2 24
$41.5B
$69.3B
Debt / Equity
CTVA
CTVA
HON
HON
Q1 26
0.14×
Q4 25
0.07×
1.95×
Q3 25
0.07×
1.79×
Q2 25
0.07×
1.87×
Q1 25
0.07×
1.47×
Q4 24
0.08×
1.37×
Q3 24
0.08×
1.49×
Q2 24
0.10×
1.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTVA
CTVA
HON
HON
Operating Cash FlowLast quarter
$0
Free Cash FlowOCF − Capex
$56.0M
FCF MarginFCF / Revenue
0.6%
Capex IntensityCapex / Revenue
1.7%
2.4%
Cash ConversionOCF / Net Profit
0.00×
TTM Free Cash FlowTrailing 4 quarters
$5.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTVA
CTVA
HON
HON
Q1 26
$0
Q4 25
$4.4B
$1.2B
Q3 25
$193.0M
$3.3B
Q2 25
$947.0M
$1.3B
Q1 25
$-2.1B
$597.0M
Q4 24
$4.2B
$2.3B
Q3 24
$130.0M
$2.0B
Q2 24
$451.0M
$1.4B
Free Cash Flow
CTVA
CTVA
HON
HON
Q1 26
$56.0M
Q4 25
$4.2B
$1.1B
Q3 25
$36.0M
$2.9B
Q2 25
$829.0M
$1.0B
Q1 25
$-2.2B
$346.0M
Q4 24
$4.0B
$1.9B
Q3 24
$-24.0M
$1.7B
Q2 24
$337.0M
$1.1B
FCF Margin
CTVA
CTVA
HON
HON
Q1 26
0.6%
Q4 25
106.2%
16.7%
Q3 25
1.4%
28.0%
Q2 25
12.8%
9.8%
Q1 25
-49.9%
3.5%
Q4 24
100.4%
18.7%
Q3 24
-1.0%
17.7%
Q2 24
5.5%
11.6%
Capex Intensity
CTVA
CTVA
HON
HON
Q1 26
1.7%
2.4%
Q4 25
5.7%
0.8%
Q3 25
6.0%
3.6%
Q2 25
1.8%
2.9%
Q1 25
2.1%
2.6%
Q4 24
4.6%
3.9%
Q3 24
6.6%
2.9%
Q2 24
1.9%
2.7%
Cash Conversion
CTVA
CTVA
HON
HON
Q1 26
0.00×
Q4 25
Q3 25
1.80×
Q2 25
0.72×
0.84×
Q1 25
-3.23×
0.41×
Q4 24
1.78×
Q3 24
1.41×
Q2 24
0.43×
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTVA
CTVA

Segment breakdown not available.

HON
HON

Aerospace Technologies$4.3B47%
Building Automation$1.9B21%
Process Automation and Technology$1.5B17%
Industrial Automation$1.4B16%
Corporate and All Other$5.0M0%

Related Comparisons